期刊文献+

HZ08冻干脂质体的制备及其逆转肿瘤多药耐药的研究 被引量:1

Preparation of lyophilized HZ08 liposomes and the reversal of multidrug resistance in tumor
下载PDF
导出
摘要 制备了HZ08冻干脂质体,考察脂质体冻干前后的包封率、粒径和长期放置稳定性等指标。通过K562/A02细胞逆转阿霉素耐药性实验,考察了HZ08冻干脂质体对逆转阿霉素耐药性作用。结果表明:制备的HZ08脂质体冻干前后包封率、粒径等指标基本相同。12周的放置实验,HZ08冻干脂质体的药物渗漏率为未冻干的25.92%,且脂质体粒径的增幅仅为未冻干的12.32%,冻干后的脂质体稳定性显著提高。10,3,1μmol/L HZ08脂质体冻干粉对K562/A02细胞具有不同程度的逆转阿霉素的耐药性作用,其逆转倍数分别为50.87、17.75和2.05。分别于3个月、6个月和12月时,取样测定批量生产的HZ08冻干脂质体的各项指标,各项指标无明显变化。 HZ08 liposomes(HL) and lyophilized HZ08 liposomes(LHL) were prepared and characterized by encapsulation efficiency(EE),particle size(PS) and long term stability.The effect of LHL on reversal of adriamycin resistance was investigated by K562/A02 cell reversal of adriamycin resistance experiment.It was found that the PS and EE had no significant change after freeze-drying of HL.However,leakage rate of LHL(12.32%) was significantly lower than that of LHL(25.92%) after 12-weeks storage.The effect of LHL on the reversal of adriamycin resistance was investigated by K562/A02 cell reversal with different concentration LHL(10,3,1 μmol/L),and the reversal fold was 50.87,17.75 and 2.05,respectively.In 3 months,6 months and 12 months,LHL was sampled to determine the quality,and there was no obvious change during the storage.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2013年第2期130-133,共4页 Journal of China Pharmaceutical University
基金 中央高校基本科研业务费专项资金资助项目(No.JKZ2011001)~~
关键词 HZ08 冻干脂质体 稳定性 肿瘤多药耐药逆转 制备 HZ08 lyophilized liposome stability reversal of multidrug resistance preparation
  • 相关文献

参考文献9

二级参考文献40

  • 1熊非,朱家壁,王维,华小兵.灯盏花素纳米脂质体包封率测定方法研究[J].药学学报,2004,39(9):755-757. 被引量:33
  • 2潘启超,田晖.多种中药单体逆转肿瘤多药耐药性[J].科学通报,1995,40(20):1901-1904. 被引量:69
  • 3王荣祺,张军,王常勇,易甫,李保罗,江红,郭希民,董宝军,段翠密,董灵芝.壳聚糖-hVEGF_(165)基因微粒的制备及体外转染的实验研究[J].中国生物医学工程学报,2006,25(1):14-18. 被引量:5
  • 4[1]Payle NI, Browning I, hynes CA. Charcaterization of proliposome [J]. J Pharm Sic, 1986, 75(4): 330-339.
  • 5[2]Perrett S, Golding M, Williams WP. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes [J]. J Pharm Pharmacol, 1991, 43(3):154-161.
  • 6[3]Anderson KE, Stevenson BR, Rogers JA. Folic Acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents [J]. J Control Release, 1999, 60(2-3): 189-198
  • 7[4]Christensen KL, Pedersen GP, Kristensen HG. Technical optimisation of redispersible dry emulsions [J]. Int J Pharm, 2001,212(2): 195-202
  • 8[5]Duchene D, Ponchel G , Wouessidjewe D. Cyclodextrins in targeting application to nanoparticles [J]. Adv Drug Deliv, 1999, 36(1): 29-40.
  • 9[6]Crowe LM, Crowe JH, Appel L, et al. Preservation of freeze-dried liposome by trehalose [J]. Arch Biochem biophys, 1985,242(1): 240-249.
  • 10[7]Murata M, Takahashi S, Kagiwada S, et al. pH-dependent membrane fusion and vesiculation of phospholipid large unilamellar vesicles induced by amphiphilic anionic and cationic peptides [J]. Biochemistry, 1992, 31(7):1986-1992 .

共引文献28

同被引文献17

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部